Can a carcinoid tumor still be suspected if an upper endoscopy (esophagogastroduodenoscopy) is clear?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Carcinoid Tumor Still Be Suspected Despite Clear Upper Endoscopy?

Yes, carcinoid tumors can absolutely still be suspected and present even when upper endoscopy appears normal, particularly for small bowel (jejunal/ileal) carcinoids which are the most common sites and frequently missed on standard endoscopy.

Why Upper Endoscopy Can Miss Carcinoid Tumors

Anatomical Limitations

  • Most carcinoid tumors occur in areas not visualized by standard upper endoscopy, particularly the jejunum and ileum, which are the most common sites for carcinoid tumors 1
  • Upper endoscopy only examines the esophagus, stomach, and proximal duodenum, missing the vast majority of the small intestine where midgut carcinoids typically arise 1
  • A patient with abdominal pain and bowel habit changes over many years is often misdiagnosed as irritable bowel syndrome when barium studies and CT scans appear normal, yet still harbors a small bowel carcinoid 1

Size and Detection Issues

  • Small carcinoid tumors can be endoscopically invisible, especially those less than 2mm in diameter 2
  • Even when present in areas accessible to endoscopy (stomach, duodenum, rectum), small lesions may be missed without careful inspection 3, 4
  • Standard endoscopy cannot reliably detect submucosal lesions without specialized techniques 2

Clinical Approach When Carcinoid Is Suspected

Biochemical Testing Remains Critical

  • Measure 24-hour urine 5-HIAA even with normal endoscopy, particularly if carcinoid syndrome symptoms (flushing, diarrhea) are present 1
  • A patient with symptoms may still have a carcinoid tumor even if 5-HIAA concentration is normal 1
  • Chromogranin A levels can be measured, though they are elevated in multiple conditions including renal/hepatic insufficiency and proton pump inhibitor use 1

Advanced Imaging Is Essential

  • Somatostatin receptor scintigraphy (Octreoscan) is the investigation of choice for localizing carcinoid tumors, with sensitivity of 72-97% for primary gastrinomas and up to 90% for foregut, midgut, and hindgut tumors 1, 5
  • Multi-phase CT or MRI of chest, abdomen, and pelvis should be performed, as NETs are highly vascular and can appear isodense with liver on conventional single-phase CT 1
  • If Octreoscan is negative and no diagnosis is reached after upper and lower endoscopy, triple-phase CT of thorax and abdomen is the investigation of choice 1, 5

Additional Endoscopic Evaluation

  • Capsule endoscopy or dedicated small bowel imaging should be considered for suspected midgut carcinoids not visualized on upper endoscopy 1
  • Colonoscopy is necessary to evaluate for colonic and rectal carcinoids 1
  • Endoscopic ultrasound (EUS) can detect submucosal lesions as small as 2mm and determine depth of invasion, with 90-100% sensitivity for pancreatic NETs 5, 2

Common Pitfalls to Avoid

Don't Stop at Normal Upper Endoscopy

  • The most common error is assuming a clear upper endoscopy rules out carcinoid tumor 1
  • Many patients with midgut carcinoids have completely normal upper endoscopy because the primary tumor is in the jejunum or ileum 1
  • Barium studies and CT scans may also be normal in early disease, showing findings only when larger lesions develop (fixation, separation, thickening, angulation, calcification) 1

Recognize Presentation Patterns

  • Many patients present with metastatic disease (especially liver metastases) with no identifiable primary site on initial imaging 1
  • Classic carcinoid syndrome typically occurs only after liver metastases develop, as liver enzymes rapidly destroy metabolic products in the portal circulation 1
  • Approximately 8-28% of patients with NETs develop carcinoid syndrome, usually indicating metastatic disease 1

Dietary and Medication Interference

  • Patients must avoid specific foods (avocados, bananas, cantaloupe, eggplant, pineapples, plums, tomatoes, hickory nuts, plantain, kiwi, dates, grapefruit, honeydew, walnuts) for 48 hours before 5-HIAA testing 1
  • Coffee, alcohol, and smoking should also be avoided during this period 1
  • Medications including acetaminophen, ephedrine, diazepam, nicotine, and phenobarbital can falsely elevate 5-HIAA levels 1

Site-Specific Considerations

Gastric Carcinoids

  • Can be missed on initial endoscopy, particularly small type I or II lesions 6
  • Follow-up endoscopy every 6-12 months is recommended for type 1 and 2 gastric carcinoids after initial detection 1
  • Microcarcinoids and enterochromaffin-like cell hyperplasias may be present but not visible macroscopically 6

Duodenal Carcinoids

  • EUS is essential for proper evaluation, as 80% of gastrinomas in MEN1 are duodenal 5
  • Upper GI endoscopy should be performed first for suspected duodenal lesions, but EUS sensitivity is lower for extrapancreatic gastrinomas 5

Rectal Carcinoids

  • In 95.9% of cases, carcinoid tumors can be suspected by macroscopic appearance during endoscopy 7
  • Proctoscopic examination is specifically recommended for suspected rectal NETs 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Endoscopic management of a primary duodenal carcinoid tumor.

Case reports in gastroenterology, 2012

Guideline

Gastrinoma Localization Investigations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A case of multiple gastric carcinoids that could not be preoperatively diagnosed.

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.